Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study.
作者:
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);丹麦(Denmark);无病生存(Disease-Free Survival);多柔比星(Doxorubicin);女(雌)性(Female);人类(Humans);预期寿命(Life Expectancy);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);泼尼松(Prednisone);缓解诱导(Remission Induction);长春新碱(Vincristine);青年人(Young Adult)
DOI
10.1200/JCO.2016.70.0765
PMID
28095160
发布时间
2019-12-10
- 浏览34

Journal of clinical oncology
778-784页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文